Ovid Therapeutics Inc.
Ovid Therapeutics Inc. (OVID) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 26 transactions totaling $5.8M, demonstrating a bullish sentiment with $5.5M in net insider flow. The most recent transaction on Jan 4, 2026 involved a transaction of 890,000 shares valued at $0.
OVID Insider Activity Summary
Who Is Buying OVID Stock?
No significant insider buying has been recorded for OVID in the recent period.
Who Is Selling OVID Stock?
No significant insider selling has been recorded for OVID in the recent period.
Is Ovid Therapeutics Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for OVID is bullish with an Insider Alignment Score of 97/100 and a net flow of $5.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
OVID Frequently Asked Questions
Understanding OVID Insider Activity
Insider trading at Ovid Therapeutics Inc. (OVID) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading OVID stock, having executed 26 transactions in the past 90 days. The most active insider is Pharmaceutical Co Ltd Takeda (Executive), who has made 3 transactions totaling $5.0M.
Related Tools
Track Ovid Therapeutics Inc. Insider Activity
Get notified when executives and directors at OVID file new Form 4 transactions